Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Partner Communications Reports First Quarter 2019 Results1

Published

on

Reading Time: 13 minutes

Adjusted EBITDA2 Totaled NIS 197
Million

Net Debt2 Remained Below NIS 1
Billion with Net Debt to Adjusted EBITDA Ratio of 1.3

Partner’s CEO, Isaac Benbenisti, Noted: “Partner’s Fiber Optics
Infrastructure Already Reaches More Than 400 Thousand Households in More
Than Half of Israel’s Cities across the Country, and Partner TV
Continues to Be the Fastest Growing Television Service in Israel with
over 152 Thousand Subscribers.”

First quarter 2019 highlights (compared with first quarter 2018)

  • Total Revenues: NIS 794 million (US$ 219 million), a
    decrease of 4%
  • Service Revenues: NIS 624 million (US$ 172 million),
    approximately unchanged
  • Equipment Revenues: NIS 170 million (US$ 47 million), a
    decrease of 15%
  • Total Operating Expenses (OPEX)2:
    NIS 472 million (US$ 130 million), a decrease of 5%
  • Adjusted EBITDA: NIS 197 million (US$ 54 million), an
    increase of 11%
  • Adjusted EBITDA Margin2: 25%
    of total revenues compared with 21%
  • Profit for the Period: NIS 2 million (US$ 1 million) a
    decrease of 78%
  • Net Debt: NIS 977 million (US$ 269 million), an increase of
    NIS 58 million
  • Adjusted Free Cash Flow (before interest)2:
    negative NIS 11 million (US$ -3 million), a decrease of NIS 32
    million
  • Cellular ARPU: NIS 56 (US$ 15), a decrease of 3%
  • Cellular Subscriber Base: approximately 2.62 million at
    quarter-end, a decrease of 1%
  • TV Subscriber Base: approximately 141 thousand subscribers
    at quarter-end, an increase of 76 thousand subscribers

ROSH HA’AYIN, Israel–(BUSINESS WIRE)–Partner
Communications Company Ltd.
(“Partner” or the “Company”)
(NASDAQ and TASE: PTNR), a leading Israeli communications provider,
announced today its results for the quarter ended March 31, 2019.

Commenting on the results for the first quarter of 2019, Mr. Isaac
Benbenisti, CEO of Partner noted:

In a saturated communications market, Partner succeeded in
starting the year 2019 with positive momentum. Partner’s fiber optics
infrastructure already reaches more than 400 thousand households in more
than half of Israel’s cities across the country, and Partner TV
continues to be the fastest growing television service in Israel with
over 152 thousand subscribers.

In the cellular segment, we continued to maintain a low rate of churn by
focusing on existing customers. This strategy is also reflected in the
moderate decrease in ARPU we recorded compared to the previous quarter
and the corresponding quarter in 2018.

In recent months, we have focused on the strategy of providing value to
Partner’s customers in all areas of the Group’s business: cellular,
internet, television and the business division. This strategy is
expected to bring results both on the revenue side and in increasing
customer loyalty with respect to all lines of products and services.

As part of this strategy, we are establishing a dedicated customer
service division that will handle all of our private customers’ needs,
across cellular and fixed line segments. We believe that this will
further strengthen Partner’s industry-leading level of service, and
differentiate us from all other players in the communications market.

Alongside continued growth in television and accelerated deployment of
the fiber optics infrastructure, we succeeded in maintaining a net debt
level of under NIS 1 billion. Partner’s financial strength offers us
considerable flexibility for making strategic investments and for
expanding activity in new and existing business areas.”

Mr. Tamir Amar, Partner’s Chief Financial Officer, commented on the
results:

“Partner closed another quarter characterized by significant competition
in its operating segments, achieving relative stability in service
revenues compared to the previous quarter, while continuing to grow its
fixed line segment activity, both in the number of subscribers and in
revenues. In the cellular segment, where competition continues to be
high, we continued to maintain a relatively low churn rate, which was
unchanged compared to the previous quarter and declined compared to the
corresponding quarter last year, and relatively low ARPU erosion by,
among other things, strategically focusing on customers that offer value
for the Company.

At the beginning of January 2019, an amendment to the network sharing
agreement between the Company and HOT Mobile was signed, as a result of
which, from the beginning of this year, the accounting treatment for the
jointly owned partnership with HOT mobile, PHI, is as a joint operation
instead of through the equity method. Therefore, the Company’s relative
share (50%) in PHI’s assets and liabilities was added to the Company’s
balance sheet. The change did not materially affect the Company’s
statement of income.

Starting with the first quarter of 2019, the Company adopted the new
accounting standard IFRS 16 – Leases, as required under IFRS. IFRS 16
requires the recognition of lease liability for lease payments and a
right-of-use asset, with respect to contracts that were previously
accounted for as operating leases. In the first quarter of 2019, the
impact of adopting IFRS 16 was an increase in Adjusted EBITDA for the
quarter by NIS 39 million.

We concluded the quarter with Adjusted Free Cash Flow (before interest
payments) of negative NIS 11 million. Cash flows from operating
activities totaled NIS 213 million. Lease payments, presented in cash
flows from financing activities, totaled NIS 39 million. CAPEX payments
totaled NIS 185 million, reflecting the Company’s strategy to continue
its leadership in telecommunications technologies with continued
significant investment in the Company’s fiber optics infrastructure.
This investment is only made possible by Partner’s strong balance sheet.

In addition, in recent months we have continued our preparations for our
future debt recycling with the private placement of untradeable option
warrants exercisable for the Company’s Series G debentures, thereby
arranging a significant portion of the Company’s expected funding
requirements for the years through 2021.”

Q1 2019 compared to Q4 2018

NIS Million   Q4’18   Q1’19   Comments
Service Revenues   625   624   The decrease resulted from decreases in cellular service revenues as
a result of seasonality and price erosion, partially offset by an
increase in fixed-line segment service revenues
Equipment Revenues 189 170 The decrease mainly reflected a lower volume of equipment sales
Total Revenues 814 794
Gross profit from equipment sales 42 39
OPEX 502 472

Excluding the impact of IFRS 16, OPEX would have totaled NIS 511
million, an increase of NIS 9 million, mainly reflecting increased
costs related to TV and internet services

Adjusted EBITDA 172 197

Excluding the impact of IFRS 16, Adjusted EBITDA would have
totaled NIS 158 million, a decrease of NIS 14 million, mainly
reflecting the increase in OPEX and the decrease in gross profit
from equipment sales

Profit for the Period 19 2 The decrease in profit was mainly a result of the decrease in
Adjusted EBITDA excluding the impact of IFRS 16 (this also reflects
the fact that the increase in depreciation expenses and in finance
costs, net, due to IFRS 16 was of similar magnitude to the increase
in Adjusted EBITDA due to IFRS 16)
Capital Expenditures (additions) 177 157
Adjusted free cash flow (before interest payments)

(22)

(11) Adjusted free cash flow increased mainly as a result of the increase
in operating assets and liabilities partially offset by the decrease
in Adjusted EBITDA (excluding the impact of IFRS 16)
Net Debt   950   977    
    Q4’18   Q1’19   Comments
Cellular Post-Paid Subscribers (end of period, thousands)   2,361   2,340   Decrease of 21 thousand subscribers

Cellular Pre-Paid Subscribers (end of period, thousands)

285 280

Decrease of 5 thousand subscribers

Monthly Average Revenue per Cellular User (ARPU) (NIS) 57 56
Quarterly Cellular Churn Rate (%)   8.5%   8.5%    

Key Financial Results Q1 2019
compared to Q1 2018

NIS MILLION (except EPS)   Q1’18   Q1’19   % Change
Revenues   826   794   -4%
Cost of revenues 688 677 -2%
Gross profit 138 117 -15%
Operating profit 32 9 -72%
Profit for the period 9 2 -78%
Earnings per share (basic, NIS) 0.05 0.01
Adjusted free cash flow (before interest)   21   (11)    

Key Operating Indicators

    Q1’18   Q1’19   Change
Adjusted EBITDA (NIS million)   177   197   +11%
Adjusted EBITDA margin (as a % of total revenues) 21% 25% +4
Cellular Subscribers (end of period, thousands) 2,649 2,620 -29
Quarterly Cellular Churn Rate (%) 8.9% 8.5% -0.4
Monthly Average Revenue per Cellular User (ARPU) (NIS)   58   56   -2

Partner Consolidated Results

  Cellular Segment   Fixed-Line Segment   Elimination   Consolidated
NIS Million   Q1’18   Q1’19   Change %   Q1’18   Q1’19   Change %   Q1’18   Q1’19   Q1’18   Q1’19   Change %
Total Revenues

644

  583   -9%

225

  252   +12%

(43)

  (41)

826

  794   -4%
Service Revenues

466

441 -5%

202

224 +11%

(43)

(41)

625

624 -0%
Equipment Revenues

178

142 -20%

23

28 +22%

201

170 -15%
Operating Profit

22

9

-59%

10

0

32

9 -72%
Adjusted EBITDA  

134

  150   +12%  

43

  47   +9%      

177

  197   +11%

Financial Review

In Q1 2019, total revenues were NIS 794 million (US$ 219
million), a decrease of 4% from NIS 826 million in Q1 2018.

Service revenues in Q1 2019 totaled NIS 624 million (US$ 172
million), a decrease of NIS 1 million from NIS 625 million in Q1 2018.

Service revenues for the cellular segment in Q1 2019 totaled NIS
441 million (US$ 121 million), a decrease of 5% from NIS 466 million in
Q1 2018. The decrease was mainly the result of the continued price
erosion of cellular services (both Post-Paid and Pre-Paid) due to the
continued competitive market conditions.

Service revenues for the fixed-line segment in Q1 2019 totaled
NIS 224 million (US$ 62 million), an increase of 11% from NIS 202
million in Q1 2018. The increase reflected revenues from TV services and
internet services, which were partially offset principally by the
decline in revenues from international calling services.

Equipment revenues in Q1 2019 totaled NIS 170 million (US$ 47
million), a decrease of 15% from NIS 201 million in Q1 2018, mainly
reflecting a lower volume of equipment sales and a change in product mix.

Gross profit from equipment sales in Q1 2019 was NIS 39
million (US$ 11 million), compared with NIS 43 million in Q1 2018, a
decrease of 9%, mainly reflecting the decline in sales volumes,
partially offset by higher profit margins from sales due to a change in
the product mix.

Total operating expenses (‘OPEX’) totaled NIS 472 million (US$
130 million) in Q1 2019, a decrease of 5% or NIS 26 million from Q1
2018. The decrease mainly reflected the effect of the implementation of
IFRS 16 which totaled NIS 39 million, a decrease in credit losses, and a
decrease in costs related to international calls. These decreases were
partially offset by an increase in expenses relating to the growth in TV
and internet services. Including depreciation and amortization expenses
and other expenses (mainly amortization of employee share based
compensation), OPEX in Q1 2019 increased by 3% compared with Q1 2018.

Operating profit for Q1 2019 was NIS 9 million (US$ 2 million), a
decrease of 72% compared with operating profit of NIS 32 million in Q1
2018. Excluding the adoption of IFRS 16, operating profit in Q1 2019
would have been NIS 4 million. See Adjusted EBITDA analysis for each
segment below.

Adjusted EBITDA in Q1 2019 totaled NIS 197 million (US$ 54
million), an increase of 11% from NIS 177 million in Q1 2018. The impact
of the adoption of IFRS 16 on Adjusted EBITDA in Q1 2019 was an increase
of NIS 39 million and, therefore, excluding the impact of IFRS 16,
Adjusted EBITDA would have been NIS 158 million. As a percentage of
total revenues, Adjusted EBITDA in Q1 2019 was 25% compared with 21% in
Q1 2018.

Adjusted EBITDA for the cellular segment was NIS 150 million (US$
41 million) in Q1 2019, an increase of 12% from NIS 134 million in Q1
2018, mainly reflecting the impact of the adoption of IFRS 16 which
increased cellular segment Adjusted EBITDA by NIS 34 million, and a
decrease in cellular operating expenses (OPEX), which were partially
offset by decreases in service revenues and in gross profit from
cellular equipment sales. As a percentage of total cellular segment
revenues, Adjusted EBITDA for the cellular segment in Q1 2019 was 26%
compared with 21% in Q1 2018.

Adjusted EBITDA for the fixed-line segment was NIS 47 million
(US$ 13 million) in Q1 2019, an increase of 9% from NIS 43 million in Q1
2018, reflecting the increases in fixed-line service revenues and in
gross profit from equipment sales, partially offset by the increase in
OPEX. The impact of the adoption of IFRS 16 in Q1 2019 on the Adjusted
EBITDA for the fixed-line segment was an increase of NIS 5 million. As a
percentage of total fixed-line segment revenues, Adjusted EBITDA for the
fixed-line segment in Q1 2019 was 19%, unchanged from Q1 2018.

Finance costs, net in Q1 2019 were NIS 14 million (US$ 4
million), a decrease of 22% compared with NIS 18 million in Q1 2018. The
decrease largely reflected the early loan repayment fee recorded in Q1
2018, partially offset by the impact of the adoption of IFRS 16 in Q1
2019, which resulted in an increase of NIS 5 million in finance costs.

Income tax expenses for Q1 2019 were an income of NIS 7 million
(US$ 2 million), compared with expenses of NIS 5 million in Q1 2018,
largely reflecting the loss before tax of NIS 5 million in Q1 2019
compared with profit before tax of NIS 14 million in Q1 2018.

Profit in Q1 2019 was NIS 2 million (US$ 1 million), compared
with a profit of NIS 9 million in Q1 2018, a decrease of 78%. The
impact of the adoption of IFRS 16 in Q1 2019 on profit was an immaterial
decrease of NIS 1 million.

Based on the weighted average number of shares outstanding during Q1
2019, basic earnings per share or ADS, was NIS 0.01 (US$ 0.003),
compared with basic earnings per share of NIS 0.05 in Q1 2018.

Cellular Segment Operational Review

At the end of Q1 2019, the Company’s cellular subscriber base
(including mobile data, 012 Mobile subscribers and M2M subscriptions)
was approximately 2.62 million, including approximately 2.34 million
Post-Paid subscribers or 89% of the base, and approximately 280 thousand
Pre-Paid subscribers, or 11% of the subscriber base.

During the first quarter of 2019, the cellular subscriber base decreased
by approximately 26 thousand. The Pre-Paid subscriber base decreased by
approximately 5 thousand, and the Post-Paid subscriber base decreased by
approximately 21 thousand.

The quarterly churn rate for cellular subscribers in Q1 2019 was
8.5%, compared with 8.9% in Q1 2018.

Total cellular market share (based on the number of subscribers)
at the end of Q1 2019 was estimated to be approximately 25%, unchanged
from Q1 2018.

The monthly Average Revenue per User (“ARPU”) for cellular
subscribers in Q1 2019 was NIS 56 (US$ 15), a decrease of 3% from NIS 58
in Q1 2018. The decrease mainly reflected the continued price erosion in
key cellular services due to the competition in the cellular market.

Funding and Investing Review

In Q1 2019, Adjusted Free Cash Flow (including lease payments) totaled
negative NIS 11 million (US$ -3 million), a decrease in Adjusted Free
Cash Flow of NIS 32 from positive NIS 21 million in Q1 2018.

Cash generated from operating activities increased by 36% from
NIS 157 million in Q1 2018 to NIS 213 million (US$ 59 million) in Q1
2019, mainly as a result of the adoption in Q1 2019 of IFRS 16, under
which lease payments are recorded in cash flows from financing
activities instead of in cash flows from operating activities, as well
as the impact of the change in the accounting treatment of PHI,
following the change in PHI’s governance (see below), where payments to
PHI for Right of Use of PHI’s assets which previously were recorded as
cash flows from operating activities under “Increase in deferred
expenses – right of use” are, as from Q1 2019, recorded as cash flows
from investing activities under “Acquisition of property and equipment”
and “Acquisition of intangible and other assets”.

Lease payments, recorded in cash flows from financing activities
under IFRS 16, totaled NIS 39 million in Q1 2019.

Cash capital expenditures (‘CAPEX payments’), as represented by
cash flows used for the acquisition of property and equipment and
intangible assets, were NIS 185 million (US$ 51 million) in Q1 2019, an
increase of 34% from NIS 138 million in Q1 2018, mainly reflecting the
impact of the change in the accounting treatment of PHI, as described
above, as well as increased investments in the fiber optics
infrastructure.

The level of Net Debt at the end of Q1 2019 amounted to NIS 977
million (US$ 269 million), compared with NIS 919 million at the end of
Q1 2018, an increase of NIS 58 million.

Change in PHI’s governance from the beginning
of 2019

At the beginning of January 2019, an amendment to the network sharing
agreement between the Company and HOT Mobile was signed, as a result of
which, control over the partnership, PHI, is now borne 50-50 by the
Company and HOT Mobile, and each nominates an equal number of directors
(three directors). Since, thereafter, decisions about the Relevant
Activities of PHI require the unanimous consent of both the Company and
HOT Mobile, PHI is considered a joint arrangement controlled by the
Company and HOT Mobile (joint operation). Therefore, from the beginning
of this year, PHI is accounted for as a joint operation by the Company,
and the Company recognizes its share (50%) in the assets, liabilities,
and expenses of PHI, instead of using the equity method for its PHI
interest.

This change was mainly reflected in the Company’s statement of financial
position at the beginning of 2019, with increases in non-current
right-of-use in leased assets of NIS 355 million, in current maturities
of lease liabilities of NIS 65 million, and in non-current lease
liabilities of NIS 290 million, and a recognition of property and
equipment and intangible assets of NIS 142 million, instead of deferred
expenses – right of use in PHI’s assets. The change was also reflected
in cash flows, where payments to PHI for Right of Use of PHI’s assets
which previously were recorded as cash flows from operating activities
under “Increase in deferred expenses – right of use” are now recorded as
cash flows from investing activities under “Acquisition of property and
equipment” and “Acquisition of intangible and other assets”. The change
did not materially affect the Company’s statement of income.

For additional details and implications, see note 9 to our consolidated
financial statements for the year ended December 31, 2018 and Item 5A.1d
in the Company’s Annual Report on Form 20-F for the year ended December
31, 2018, filed with the SEC on March 27, 2019.

IFRS 16

The new leases standard, IFRS 16, came into effect on January 1, 2019.
The standard primarily affects the accounting for the Group’s operating
leases. The Company applied the simplified transition approach and did
not restate comparative amounts. As at January 1, 2019, the Company
recognized in the statement of financial position (including Partner’s
share in PHI’s lease contracts) a Lease – right of use asset of NIS 656
million and a lease liability of NIS 683 million (current and
non-current). The accumulated retained earnings decreased by NIS 21
million and the deferred income tax asset has changed in an immaterial
amount.

In the first quarter of 2019, the impact of adopting IFRS 16 on the
consolidated statement of income amounted to a decrease of NIS 39
million in operating expenses (OPEX), an increase of NIS 35 million in
depreciation and amortization expenses and an increase of NIS 5 million
in finance costs, net, which resulted in an immaterial increase in
operating profit and an immaterial decrease in profit for the quarter.
Adjusted EBITDA for the quarter increased by NIS 39 million, with
Adjusted EBITDA for the cellular segment increasing by NIS 34 million
and Adjusted EBITDA for the fixed-line segment increasing by NIS 5
million.

Lease payments made in the first quarter of 2019 in an amount of NIS 39
million were recorded in the statement of cash flows under the cash
flows from financing activities instead of under cash flows from
operating activities.

Conference Call Details

Partner will hold a conference call on Thursday, May 30, 2019 at 10.00AM
Eastern Time / 5.00PM Israel Time.

To join the call, please dial the following numbers (at least 10 minutes
before the scheduled time):

International: +972.3.918.0685

North America toll-free: +1.866.860.9642

A live webcast of the call will also be available on Partner’s Investors
Relations website at: www.partner.co.il/en/Investors-Relations/lobby/

If you are unavailable to join live, the replay of the call will be
available from May 30, 2019 until June 14, 2019, at the following
numbers:

International: +972.3.925.5929

North America toll-free: +1.888.254.7270

In addition, the archived webcast of the call will be available on
Partner’s Investor Relations website at the above address for
approximately three months.

Forward-Looking Statements
This
press release includes forward-looking statements within the meaning of
Section 27A of the US Securities Act of 1933, as amended, Section 21E of
the US Securities Exchange Act of 1934, as amended, and the safe harbor
provisions of the US Private Securities Litigation Reform Act of 1995.
Words such as “estimate”, “believe”, “anticipate”, “expect”, “intend”,
“seek”, “will”, “plan”, “could”, “may”, “project”, “goal”, “target” and
similar expressions often identify forward-looking statements but are
not the only way we identify these statements. Specific statements have
been made regarding the expected benefits of the Company’s strategy to
provide value to its customers in all areas of its business; the
expectation to increase the Company’s differentiation and competitive
advantage by establishing a private customer service division; the
Company’s strategy to continue its leadership in telecommunication
technologies with continued significant investments in the Company’s
fiber optics infrastructure; and the Company’s preparations regarding
its future debt recycling in anticipation of the Company’s expected
funding requirements for the years through 2021. In addition, all
statements other than statements of historical fact included in this
press release regarding our future performance are forward-looking
statements. We have based these forward-looking statements on our
current knowledge and our present beliefs and expectations regarding
possible future events. These forward-looking statements are subject to
risks, uncertainties and assumptions, including, whether quality offers,
attractive service bundles or low prices offered by the Company’s
competitors might prevent the Company from attracting and retaining
customers; whether market conditions will support the Company’s goal to
create differentiation and a competitive advantage by establishing a
private customer service division; whether the Company’s financial
resources and technological capabilities in fiber optics will enable it
to continue to lead in telecommunication technology, and whether such
leadership might be challenged by capabilities developed by competitors
or by changes occurring in the regulatory environment; and whether
unanticipated demands on the Company’s financial resources might cause
the preparations for future debt recycling to fall short of the
Company’s needs.

Contacts

Tamir Amar
Chief Financial Officer
Tel: +972-54-781-4951
E-mail:
[email protected]

Read full story here


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Medical Cannabis Market Report 2024-2030: Asia-Pacific Set to Witness Robust Growth, Driven by R&D Discovery Initiatives

Published

on

Continue Reading

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania